Skip to main content
Barhemsys 2.5 mg/mL injection, solution by Acacia Pharma Ltd
Barhemsys, 2.5 mg/mL, injection, solution Drug class: Dopamine-2 Receptor Antagonist. Available on prescription only. Listed by Acacia Pharma Ltd.
Prescription only

Barhemsys

Amisulpride

Listed by Acacia Pharma Ltd

Strength
2.5 mg/mL
Form
Injection, Solution
Route
Intravenous
Class
Dopamine-2 Receptor Antagonist

What it contains

  • Amisulpride 2.5 mg/mL

FDA record

Dosage form Injection, Solution
Route Intravenous
Drug class Dopamine-2 Receptor Antagonist
Approval route NDA — original brand approval
NDC code 71390-125
FDA application NDA209510
RxNorm concept 2284232
Package sizes listed 2
Marketed since February 2020

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.